Phibro Animal Health (NASDAQ:PAHC) Updates Q4 2021 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHC) updated its fourth quarter 2021 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.300-0.320 for the period, compared to the Thomson Reuters consensus estimate of $0.280. The company issued revenue guidance of $213 million-$217 million, compared to the consensus revenue estimate of $200.14 million.Phibro Animal Health also updated its FY 2021 guidance to 1.250-1.270 EPS.

Shares of PAHC stock traded up $0.51 during trading hours on Friday, hitting $27.52. The company had a trading volume of 135,266 shares, compared to its average volume of 138,763. The company has a debt-to-equity ratio of 1.97, a current ratio of 2.88 and a quick ratio of 1.61. The stock has a market capitalization of $1.11 billion, a PE ratio of 25.96, a price-to-earnings-growth ratio of 2.00 and a beta of 0.46. The company’s fifty day moving average is $25.01 and its 200 day moving average is $21.74. Phibro Animal Health has a fifty-two week low of $16.27 and a fifty-two week high of $28.22.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Thursday, May 6th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.31 by $0.03. Phibro Animal Health had a return on equity of 23.70% and a net margin of 5.37%. Equities analysts forecast that Phibro Animal Health will post 1.06 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 23rd. Shareholders of record on Wednesday, June 2nd will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.74%. The ex-dividend date of this dividend is Tuesday, June 1st. Phibro Animal Health’s dividend payout ratio is currently 44.44%.

Separately, Morgan Stanley raised their price objective on shares of Phibro Animal Health from $19.00 to $22.00 and gave the company an underweight rating in a research note on Thursday.

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: Relative Strength Index

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.